Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy

Shimomura, Iichiro, Hammer, Robert E., Ikemoto, Shinji, Brown, Michael S., Goldstein, Joseph L.·1999·Nature
DOI 10.1038/43448

Cited by (1,000)

Items 401–500 of 1,000

  1. Understanding adipose tissue development from transgenic animal models
    Philippe Valet, Genevieéve Tavernier, Isabelle Castan‐Laurell, Jean Sébastien Saulnier‐Blache, Dominique Langin · 2002 · Journal of Lipid Research
  2. Myostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy
    Tingqing Guo, Nichole D. Bond, William Jou, Oksana Gavrilova, Jennifer Portas, Alexandra C. McPherron · 2012 · Diabetes
  3. Development of insulin resistance and hyperphagia in Zucker fatty rats
    Holiday A. Durham, Gary E. Truett · 2005 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  4. Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Adiposity and Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep
    Rodolfo C. Cardoso, Almudena Veiga‐Lopez, Jacob Moeller, Evan M. Beckett, Anthony Paul Pease, E. Keller, V. Madrigal, Gregorio Daniel Chazenbalk, Daniel Anthony Dumesic, Vasantha Padmanabhan · 2015 · Endocrinology
  5. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin‐targeted keratinocyte grafts
    Fernando Larcher, Marcela Del Río, Fernando Serrano, Jose Carlos Segovia, Ángel Ramı́rez, Álvaro Meana, Angustias Page, José Luis Abad, Manuel A. GonzáLez, Juan Antonio Bueren et al. · 2001 · The FASEB Journal
  6. Influence of Insulin Resistance and Adipokines in the Grade of Steatosis of Nonalcoholic Fatty Liver Disease
    R. Aller, Daniel Antonio de Luis, Luis Ignacio Fernández-Salazar, Fernando Calle, Benito Velayos, Jose Luis Olcoz, Olatz Izaola, Manuel Gonzalez Sagrado, Rosa Conde, José Manuel Domínguez González · 2007 · Digestive Diseases and Sciences
  7. Adipocytokines: Emerging therapeutic targets
    Yūji Matsuzawa · 2005 · Current Atherosclerosis Reports
  8. Insulin Resistance: A Proinflammatory State Mediated by Lipid‐Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
    Fabrizio Montecucco, Sabine Steffens, François Mach · 2008 · Mediators of Inflammation
  9. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus
    Sunaina Gautam, Monisha Banerjee · 2010 · Molecular Genetics and Metabolism
  10. Diet, obesity and diabetes: a current update
    Celia G. Walker, Mohammed Gulrez Zariwala, Mark J. Holness, Mary C. Sugden · 2006 · Clinical Science
  11. Genetic determinants of type 2 diabetes mellitus
    CP Busch, Robert Alexander Hegele · 2001 · Clinical Genetics
  12. Rethinking the central causes of diabetes
    Joel Keith Elmquist, Jacob Marcus · 2003 · Nature Medicine
  13. Adipokines in the treatment of diabetes mellitus and obesity
    Victoria Catalán, Javier Gómez‐Ambrosi, Amaia Rodrı́guez, Javier Salvador, Gema Frühbeck · 2009 · Expert Opinion on Pharmacotherapy
  14. Adipokines and Hepatic Insulin Resistance
    Li J. Yu, Lin Ding, Waseem Hassan, Abdelkader Daoud, Jing Shang · 2013 · Journal of Diabetes Research
  15. Extracellular Signal–Regulated Kinase in the Ventromedial Hypothalamus Mediates Leptin-Induced Glucose Uptake in Red-Type Skeletal Muscle
    Chitoku Toda, Tetsuya Shiuchi, Haruaki Kageyama, Shiki Okamoto, Eulalia A. Coutinho, Tatsuya Sato, Yuko Okamatsu‐Ogura, Shigefumi Yokota, Kazuyo Takagi, Lijun Tang et al. · 2013 · Diabetes
  16. The ORlistat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORliCARDIA) study
    Triantafyllos Didangelos, Anastasia C. Thanopoulou, Stavros Bousboulas, Christos Sambanis, Vasilios Gabriel Athyros, Elefteria Spanou, Kostantina Dimitriou, Stavros I. Pappas, Basil G. Karamanos, Dimitrios T. Karamitsos · 2004 · Current Medical Research and Opinion
  17. Hypothalamic Agouti-Related Peptide Neurons and the Central Melanocortin System Are Crucial Mediators of Leptin’s Antidiabetic Actions
    Gabriel Henrique Marques Gonçalves, Wenjing Li, Adriana V.C.-G. Garcia, Mariana Sarto Figueiredo, Christian Bjørbæk · 2014 · Cell Reports
  18. LMNA R482Q Mutation in Partial Lipodystrophy Associated with Reduced Plasma Leptin Concentration
    Robert Alexander Hegele, Henian Cao, Murray W. Huff, Carol M. Anderson · 2000 · The Journal of Clinical Endocrinology & Metabolism
  19. Leptin-Replacement Therapy in Lipodystrophy
    Joseph I. Wolfsdorf, Ab Sadeghi‐Nejad, Boris Senior · 2002 · New England Journal of Medicine
  20. Leptin in congenital and HIV-associated lipodystrophy
    Michael A. Tsoukas, Olivia M. Farr, Christos Socrates Mantzoros · 2014 · Metabolism
  21. Leptin Deficiency and Beta-Cell Dysfunction Underlie Type 2 Diabetes in Compound Akt Knockout Mice
    William S. Chen, Xiao-ding Peng, Yong Wang, Pei-Zhang Xu, Mei-Ling Chen, Luo Yongmei, Sang‐Min Jeon, Kevin G. Coleman, Wanda M. Haschek, Joseph T. Bass et al. · 2009 · Molecular and Cellular Biology
  22. Effects of a Low-Fat versus a Low-Carbohydrate Diet on Adipocytokines in Obese Adults
    Daniel Antonio de Luis, R. Aller, Olatz Izaola, Manuel Gonzalez Sagrado, D. Bellioo, Rosa Conde · 2007 · Hormone Research in Paediatrics
  23. Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome
    Neeraj Desai, Amanda Roman, Burton L. Rochelson, Madhu Gupta, Xiangying Xue, Prodyot K. Chatterjee, Hima Tam Tam, Christine Noel Metz · 2013 · American Journal of Obstetrics and Gynecology
  24. Rethinking leptin and insulin action: Therapeutic opportunities for diabetes
    Bülent Okan Yıldız, İbrahim C. Haznedaroğlu · 2005 · The International Journal of Biochemistry & Cell Biology
  25. Skeletal Muscle AMP-Activated Protein Kinase Phosphorylation Parallels Metabolic Phenotype in Leptin Transgenic Mice Under Dietary Modification
    Tomohiro Tanaka, Shuji Hidaka, Hiroaki Masuzaki, Shintaro Yasue, Yasuhiko Minokoshi, Ken Ebihara, Hideki Chusho, Yoshihiro Ogawa, Tarō Toyoda, Kenji Sato et al. · 2005 · Diabetes
  26. Resistance to leptin-replacement therapy in Berardinelli–Seip congenital lipodystrophy: an immunological origin
    Jacques Beltrand, Najiba Lahlou, Tifenn Le Charpentier, Guy H. Sebag, Sofia Leka, Michel Polak, Nadia Tubiana‐Rufi, Didier Lacombe, Marc de Kerdanet, Frédéric Huet et al. · 2010 · European Journal of Endocrinology
  27. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2 lipodystrophic mice independent of hepatocyte leptin receptors
    Vı́ctor Cortés, Kelly M. Cautivo, Shunxing Rong, Abhimanyu Garg, Jay D. Horton, Anil K. Agarwal · 2013 · Journal of Lipid Research
  28. Developmental and extrahepatic physiological functions of SREBP pathway genes in mice
    Luke J. Engelking, Mary Jo Cantoria, Yanchao Xu, Guosheng Liang · 2017 · Seminars in Cell and Developmental Biology
  29. The Mevalonate Pathway Is Indispensable for Adipocyte Survival
    Yu‐Sheng Yeh, Huei‐Fen Jheng, Mari Iwase, Minji Kim, Shinsuke Mohri, Jungin Kwon, Satoko Kawarasaki, Yongjia Li, Haruya Takahashi, Takeshi Ara et al. · 2018 · iScience
  30. A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes
    Marc L. Reitman, Oksana Gavrilova · 2000 · International Journal of Obesity
  31. Leptin physiology and pathophysiology in energy homeostasis, immune function, neuroendocrine regulation and bone health
    Konstantinos Stefanakis, Jagriti Upadhyay, Arantxa Ramirez-Cisneros, Nihar Patel, Akshat Sahai, Christos Socrates Mantzoros · 2024 · Metabolism
  32. Diabetes and Suppressors of Cytokine Signaling Proteins
    Sif Groth Rønn, Nils Billestrup, Thomas R Mandrup-Poulsen · 2007 · Diabetes
  33. One‐year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes
    Camille Vatier, S. Fetita, Philippe Boudou, C. Tchankou, L. Deville, Jean‐Pierre Riveline, Jacques Young, Laurence Mathivon, Florence Travert, Denis Morin et al. · 2015 · Diabetes Obesity and Metabolism
  34. Decreased Plasma Adiponectin Levels in Young Obese Males.
    Taketaka Hara, Hiroshi Fujiwara, Tetsuo Shoji, Tatsuya Mimura, Hayato Nakao, Shigeo Fujimoto · 2003 · Journal of Atherosclerosis and Thrombosis
  35. Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms
    Takahashi, Hirokazu, Kotani, Kazuhiko, Tanaka, Kenichi, Egucih, Yuichiro, Anzai, Keizo · 2018 · Frontiers in Endocrinology
  36. Leptin mediates the regulation of muscle mass and strength by adipose tissue
    Kelsey H. Collins, Chang Gui, Erica V. Ely, Kristin L. Lenz, Charles Andrew Harris, Farshid Guilak, Gretchen A. Meyer · 2022 · The Journal of Physiology
  37. The Dual Role of the Pervasive “Fattish” Tissue Remodeling With Age
    Maria Conte, Morena Martucci, Marco Sandri, Claudio Franceschi, Stefano Salvioli · 2019 · Frontiers in Endocrinology
  38. Low serum adiponectin levels in subjects born small for gestational age: impact on insulin sensitivity
    D. Jaquet, S. Deghmoun, Didier Chevenne, Paul Czernichow, Claire Lévy‐Marchal · 2005 · International Journal of Obesity
  39. Insulin Resistance and Lipodystrophy in Mice Lacking Ribosomal S6 Kinase 2
    Karim El-Haschimi, Scott D. Dufresne, Michael F. Hirshman, Jeffrey S. Flier, Laurie J. Goodyear, Christian Bjørbæk · 2003 · Diabetes
  40. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of <i>ob/ob</i> mice
    Delporte, Marie-Laure, El Mkadem, Samira Ait, Quisquater, Muriel, Brichard, Sonia M. · 2004 · American Journal of Physiology-Endocrinology and Metabolism
  41. Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes
    Bak, E J, Park, H G, Kim, J M, Kim, J M, Yoo, Y-J, Cha, J-H · 2010 · International Journal of Obesity
  42. Lipodystrophies: adipose tissue disorders with severe metabolic implications
    Vı́ctor Cortés, Marta Fernández‐Galilea · 2015 · Journal of Physiology and Biochemistry
  43. Cytokine Abnormalities in the Etiology of the Cardiometabolic Syndrome
    Vincent Gerard DeMarco, Megan S. Johnson, Adam T. Whaley‐Connell, James R. Sowers · 2010 · Current Hypertension Reports
  44. The Unique Cysteine Knot Regulates the Pleotropic Hormone Leptin
    Ellinor Haglund, Joanna Ida Sulkowska, Zhao He, Gen‐Sheng Feng, Patricia Ann Jennings, José N. Onuchic · 2012 · PLoS ONE
  45. Metabolic consequences of lipodystrophy in mouse models
    Karen Reue, Jack Phan · 2006 · Current Opinion in Clinical Nutrition & Metabolic Care
  46. Nonalcoholic Fatty Liver Disease
    Paul D. Berk, Elizabeth C. Verna · 2016 · Clinics in Liver Disease
  47. Adipocyte alterations in endometriosis: reduced numbers of stem cells and microRNA induced alterations in adipocyte metabolic gene expression
    Masoumeh Majidi Zolbin, Ramanaiah Mamillapalli, Sepide Nematian, Teddy G. Goetz, Hugh Stott Taylor · 2019 · Reproductive Biology and Endocrinology
  48. Leptin as a Key between Obesity and Cardiovascular Disease
    Ki‐Woon Kang, Minho Ok, Seong‐Kyu Lee · 2020 · Journal of Obesity & Metabolic Syndrome
  49. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation
    Kari M. Wojtanik, Keith Edgemon, Srikant Viswanadha, Brigette Lindsey, Martin Haluzı́k, Weiping Chen, George Poy, Marc L. Reitman, Constantine Londos · 2009 · Journal of Lipid Research
  50. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity
    da Silva, Alexandre A., Tallam, Lakshmi S., Liu, Jiankang, Hall, John E. · 2006 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  51. Ischemic Stroke and Glucose Intolerance: a Review of the Evidence and Exploration of Novel Therapeutic Targets
    Shinichi Harada, Wakako Fujita‐Hamabe, Shogo Tokuyama · 2011 · Journal of Pharmacological Sciences
  52. Stimulation by Eicosapentaenoic Acids of Leptin mRNA Expression and Its Secretion in Mouse 3T3-L1 Adipocytes in Vitro
    Masahiro Murata, Hidesuke Kaji, Yutaka Takahashi, Keiji Iida, Ishikazu Mizuno, Yasuhiko Okimura, Hiromi Abe, Kazuo Chihara · 2000 · Biochemical and Biophysical Research Communications
  53. Leptin as an adjunct of insulin therapy in insulin-deficient diabetes
    Fumiko Miyanaga, Yoshihiro Ogawa, Ken Ebihara, S. Hidaka, Takuma Tanaka, S. Hayashi, Hiroaki Masuzaki, Kazuwa Nakao · 2003 · Diabetologia
  54. Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients
    Gilberto Paz-Filho, Karin F. Esposito, Barry E. Hurwitz, A. M. Sharma, Chuanhui Dong, Victor Andreev, Tuncay Delibaşı, Halil Kutlu Erol, Alejandro Raul Ayala, Ma‐Li Wong et al. · 2008 · American Journal of Physiology-Endocrinology and Metabolism
  55. Dendritic cells and adipose tissue
    Sandeep Sundara Rajan, Maria Paula Longhi · 2016 · Immunology
  56. Mouse models of lipodystrophy: Key reagents for the understanding of the metabolic syndrome
    Ingrid Wernstedt Asterholm, Nils Halberg, Philipp E. Scherer · 2007 · Drug Discovery Today Disease Models
  57. Opposite Effects of Background Genotype on Muscle and Liver Insulin Sensitivity of Lipoatrophic Mice
    Carlo Colombo, Martin Haluzı́k, Jaime J. Cutson, Kelly R. Dietz, Bernice Marcus‐Samuels, Charles Vinson, Oksana Gavrilova, Marc L. Reitman · 2003 · Journal of Biological Chemistry
  58. Aging Per Se Does Not Influence Glucose Homeostasis
    Pascal Imbeault, Johannes B. Prins, Manuela Stolic, Anthony William Russell, Trisha M O'Moore‐Sullivan, Jean‐Pierre Després, Claude Bouchard, Angelo Tremblay · 2003 · Diabetes Care
  59. The role of adipokines in relation to HIV lipodystrophy
    Laura L. Sweeney, Aoife Brennan, Christos Socrates Mantzoros · 2007 · AIDS
  60. Molecular Mechanisms of Insulin Resistance in Diabetes
    Soumaya Kouidhi · 2012 · Advances in experimental medicine and biology
  61. Association of Vitamin D Receptor-Gene ( FokI ) Polymorphism with Calcium Oxalate Nephrolithiasis
    Hemant Kumar Bid, Ajay Kumar, Rakesh K. Kapoor, Rama Devi Mittal · 2005 · Journal of Endourology
  62. The clinical uses of leptin
    Ph. Gorden, Oksana Gavrilova · 2003 · Current Opinion in Pharmacology
  63. Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes
    Junji Kawashima, Kaku Tsuruzoe, Hiroyuki Motoshima, Atsuhisa Shirakami, Koji Sakai, Yoshiaki Hirashima, T. Toyonaga, Eiichi Araki · 2003 · Diabetologia
  64. Early events involved in the development of insulin resistance in Zucker fatty rat
    RH Liu, Masanari Mizuta, Takeshi Kurose, Shigeru Matsukura · 2002 · International Journal of Obesity
  65. Leptin: A new therapeutic target for treatment of diabetes mellitus
    Kanwal Rehman, Muhammad Sajid Hamid Akash, Zunaira Alina · 2017 · Journal of Cellular Biochemistry
  66. Minireview: Obesity and LipOdystrophy—Where Do the Circles Intersect?
    Farid F. Chehab · 2008 · Endocrinology
  67. Effects of lifestyle modification on adipocytokine levels in obese patients.
    Daniel Antonio de Luis, R. Aller, Olatz Izaola, Manuel Gonzalez Sagrado, Rosa Conde, Pérez Castrillón Jl · 2008 · PubMed
  68. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
    Franck Mauvais‐Jarvis, C.Ronald Kahn · 2000 · PubMed
  69. Visceral adipose tissue: emerging role of gluco‐ and mineralocorticoid hormones in the setting of cardiometabolic alterations
    Marco Boscaro, Gilberta Giacchetti, Vanessa Ronconi · 2012 · Annals of the New York Academy of Sciences
  70. Bone Mineral Content in Patients With Congenital Generalized Lipodystrophy Is Unaffected by Metreleptin Replacement Therapy
    John David Christensen, Andreea O. Lungu, Elaine K. Cochran, Michael Terrence Collins, Rachel Ilana Gafni, James C. Reynolds, Kristina I. Rother, Phillip Görden, Rebecca J. Brown · 2014 · The Journal of Clinical Endocrinology & Metabolism
  71. The role of leptin in obesity and the potential for leptin replacement therapy
    Helin Feng, Lihua Zheng, Zhangying Feng, Yaheng Zhao, Ning Zhang · 2012 · Endocrine
  72. Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats
    Jussara Marcia do Carmo, John Edward Hall, Alexandre A. da Silva · 2008 · American Journal of Physiology-Heart and Circulatory Physiology
  73. Metabolic actions of hypothalamic SIRT1
    Roberto Coppari · 2012 · Trends in Endocrinology and Metabolism
  74. Type 2 Diabetes Mellitus
    Kenneth S. Polonsky, Charles Burant · 2016 · Elsevier eBooks
  75. Gene and Phenotype Analysis of Congenital Generalized Lipodystrophy in Japanese: A Novel Homozygous Nonsense Mutation in Seipin Gene
    Ken Ebihara, Toru Kusakabe, Hiroaki Masuzaki, Nozomi Kobayashi, Tomohiro Tanaka, Hideki Chusho, Fumiko Miyanaga, Takashi Miyazawa, Tatsuya Hayashi, Kiminori Hosoda et al. · 2004 · The Journal of Clinical Endocrinology & Metabolism
  76. Leptin, skeletal muscle lipids, and lipid-induced insulin resistance
    John J. Dubé, Bankim A. Bhatt, Nikolas Dedousis, Arend Bonen, Robert Martin O'Doherty · 2007 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  77. Organokines in disease
    2020 · Advances in clinical chemistry
  78. Adipose lipolysis is important for ethanol to induce fatty liver in the NIAAA murine model of chronic and binge ethanol feeding
    M. Mathur, Yu-Te Yeh, Rakesh K. Arya, Long Jiang, M. Pornour, Wei-Ping Chen, Yin-Yan Ma, Bin Gao, Ling He, Z. Ying et al. · 2022 · Hepatology
  79. Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin
    Annett Hoffmann, Thomas Ebert, Nora Klöting, Janine Dokas, Franziska Jeromin, Beate Jeßnitzer, Ralph Burkhardt, Mathias Faßhauer, Susan Kralisch · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  80. Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation
    Satya P. Kalra · 2009 · Peptides
  81. Leptin in nonalcoholic fatty liver disease
    Billur Canbakan, Veysel Tahan, Huriye Balcı, İbrahim Hatemı, Burak Erer, Gülşen Özbay, Necdet Süt, Münire Hacıbekiroğlu, Neşe İmeryüz, Hakan Şentürk · 2008 · Annals of Hepatology
  82. Adipokines in the HIV/HAART-associated lipodystrophy syndrome
    Jason Paruthi, Natasha Gill, Christos Socrates Mantzoros · 2013 · Metabolism
  83. Leptin, diabetes, and the brain
    Gregory J. Morton, Thomas H. Meek · 2012 · Indian Journal of Endocrinology and Metabolism
  84. Lipin Deficiency Impairs Diurnal Metabolic Fuel Switching
    Jun Xu, W.N. Paul Lee, Jack Phan, Mohammed F. Saad, Karen Reue, Irwin J. Kurland · 2006 · Diabetes
  85. Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications
    Sotirios Tsiodras, Christos Socrates Mantzoros · 2006 · American Journal of Infectious Diseases
  86. Evaluation of weight loss and adipocytokines levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs9939609 gene variant
    Daniel Antonio de Luis, R. Aller, Olatz Izaola, Beatriz de la Fuente, Rosa Conde, Manuel Gonzalez Sagrado, David Primo · 2012 · Diabetes/Metabolism Research and Reviews
  87. Acute Disruption of Leptin Signaling in Vivo Leads to Increased Insulin Levels and Insulin Resistance
    Jasna Levi, Sarah Louise Gray, Madeleine Speck, Frank K. Huynh, Sandra L. Babich, William T. Gibson, Timothy J. Kieffer · 2011 · Endocrinology
  88. The blind men 'see' the elephant-the many faces of fatty liver disease
    Sanal Madhusudana Girija · 2008 · World Journal of Gastroenterology
  89. Conjugated Linoleic Acid-Induced Fatty Liver Can Be Attenuated by Combination with Docosahexaenoic Acid in C57BL/6N Mice
    Teruyoshi Yanagita, Yuming Wang, Koji Nagao, Yoko Ujino, Nao Inoue · 2005 · Journal of Agricultural and Food Chemistry
  90. PPARγ2Pro12Ala Polymorphism and Human Health
    Weimin He · 2009 · PPAR Research
  91. PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat
    Jeffrey F. Waring, Rita Ciurlionis, Jill E. Clampit, Sherry J. Morgan, Rebecca J. Gum, Robert A. Jolly, Paul Kroeger, Leigh Frost, James M. Trevillyan, Bradley A. Zinker et al. · 2003 · Molecular and Cellular Endocrinology
  92. Adrenalectomy Improves Diabetes in A-ZIP/F-1 Lipoatrophic Mice by Increasing Both Liver and Muscle Insulin Sensitivity
    Martin Haluzı́k, Kelly R. Dietz, Jason K. Kim, Bernice Marcus‐Samuels, Gerald I. Shulman, Oksana Gavrilova, Marc L. Reitman · 2002 · Diabetes
  93. The gut–brain axis in appetite, satiety, food intake, and eating behavior: Insights from animal models and human studies
    Georgia S. Clarke, Amanda J. Page, Sally Eldeghaidy · 2024 · Pharmacology Research & Perspectives
  94. Influence of ALA54THR Polymorphism of Fatty Acid Binding Protein 2 on Lifestyle Modification Response in Obese Subjects
    Daniel Antonio de Luis, R. Aller, Olatz Izaola, Manuel Gonzalez Sagrado, Rosa Conde · 2006 · Annals of Nutrition and Metabolism
  95. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C
    Steve Wong, Mohammed S.B. Huda, Patrick English, A Bargiotta, John P.H. Wilding, A. Johnson, R. J. M. Corrall, Jonathan H. Pinkney · 2005 · Diabetologia
  96. Evidence from clinical studies of leptin: current and future clinical applications in humans
    Nikolaos Perakakis, Christos Socrates Mantzoros · 2024 · Metabolism
  97. Leptin: a novel therapeutic role in lipodystrophy
    David B. Savage, Stephen O’Rahilly · 2002 · Journal of Clinical Investigation
  98. Induction of glucose uptake in skeletal muscle by central leptin is mediated by muscle β2-adrenergic receptor but not by AMPK
    Tetsuya Shiuchi, Chitoku Toda, Shiki Okamoto, Eulalia A. Coutinho, Kumiko Saito, Shinji Miura, Osamu Ezaki, Yasuhiko Minokoshi · 2017 · Scientific Reports
  99. Biochemical and Physiological Characteristics of Fat Cell.
    Teruo Kawada, Nobuyuki Takahashi, Tohru Fushiki · 2001 · Journal of Nutritional Science and Vitaminology
  100. The liver in obesity and type 2 diabetes mellitus
    Zhiping Li, Jeanne M. Clark, Anna Mae Diehl · 2002 · Clinics in Liver Disease